Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-14 · accession 0001209191-22-037635 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-16 | 2022-06-14 | RXRX | Dar Zavain | Dir | A - Grant | $0.00 | +18.1K | 18.1K | New | $0 |
| D | 2022-06-16 | 2022-06-14 | RXRX | Dar Zavain | Dir | A - Grant | $0.00 | +36.3K | 36.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-06-14 | A | A | 18,145 | $0.00 | 18,145 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-06-14 | A | A | 36,290 | $0.00 | 36,290 | D | $6.20 · 2023-06-14 to 2032-06-14 | 36,290 Class A Common Stock |